Antigenic analysis of Rift valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains

Bernard, 1979, Rift Valley fever vaccine — antibody and immune response in cattle to a live and an inactivated vaccine, J.S. Afr. vet. med. Ass., 50, 155 Battles, 1988, Genetic variation among geographic isolates of Rift Valley fever virus, Amer. J. trop. Med. Hyg., 39, 617, 10.4269/ajtmh.1988.39.617 Besselaar, 1988, Antigenic analysis of West Nile virus strains using monoclonal antibodies, Arch. Virol., 99, 75, 10.1007/BF01311025 Besselaar, T.G. & Blackburn, N.K., Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies. Arch. Virol. (in press). Cash, 1981, Biochemical characterization of Rift Valley fever and other phlebotomus fever group viruses, Contr. Epidem. Biostat., 3, 1 Clarke, 1958, Techniques for haemagglutination and haemagglutination inhibition with arthropod-borne viruses, Amer. J. trop. Med. Hyg., 7, 561, 10.4269/ajtmh.1958.7.561 Daubney, 1931, Enzootic hepatitis or Rift Valley fever: an undescribed virus disease of sheep, cattle and man from East Africa, J. Path. Bact., 34, 546, 10.1002/path.1700340418 Gear, 1951, Rift Valley fever in South Africa. — 2. The occurrence of human cases in the Orange Free State, the Northwestern Cape Province, the Western and Southern Transvaal, S. Afr. med. J., 25, 908 Holland, 1982, Rapid evolution RNA genomes, Science, 215, 1577, 10.1126/science.7041255 Johnson, 1990, Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein, Virology, 177, 676, 10.1016/0042-6822(90)90533-W McIntosh, 1980, Rift Valley fever in humans in South Africa, S. Afr. med. J., 58, 803 Meegan, 1981, Rift Valley fever in Egypt: an overview of the epizootics in 1977 and 1978, Contr. Epidem. Biostat., 3, 100 Peters, 1981, Pathogenesis of Rift Valley fever, Contr. Epidem. Biostat., 3, 21 Randall, 1962, The development of a formalin-killed Rift Valley fever virus vaccine for use in man, J. Immunol., 89, 660, 10.4049/jimmunol.89.5.660 Saluzzo, 1989, Biological and antigenic relationship between Rift Valley fever virus strains isolated in Egypt and Madagascar, Trans. roy. Soc. trop. Med. Hyg., 83, 701, 10.1016/0035-9203(89)90402-1 Saluzzo, 1989, Antigenic and biological properties of Rift Valley fever virus isolated during the 1987 Mauritanian epidemic, Res. Virol., 140, 155, 10.1016/S0923-2516(89)80093-7 Smithburn, 1949, Rift Valley fever: the neurotropic adaptation of virus and experimental use of this modified virus as a vaccine, Brit. J. exp. Path., 30, 1 Stanley, 1985, Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus, J. Virol., 56, 110, 10.1128/JVI.56.1.110-119.1985 Swanepoel, 1986, Comparison of techniques for demonstrating antibodies to Rift Valley fever virus, J. Hyg. (Camb.), 97, 317, 10.1017/S0022172400065414 Swanepoel, 1979, Fatal Rift Valley fever of man in Rhodesia, Cent. Afr. J. Med., 25, 1 Van Velden, 1977, Rift Valley fever affecting humans in South Africa: a clinicopathological study, S. Afr. med. J., 51, 867